UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care

21 scientific presentations, including 7 late breakers, showcase the breadth of UCB's portfolio, reinforcing commitment to improving the lives of people living...

Related Keywords

Tennessee ,United States ,Nashville ,Brussels ,Bruxelles Capitale ,Belgium ,Smyrna ,Izmir ,Turkey ,American ,Victor Soto Insuga ,Joseph Sullivan ,Nick Francis ,Antje Witte ,Kimi Bishop ,Anuj Jayakar ,Kellyg Knupp ,Brad Chapman ,Kerstin Alexandra Klotz ,Edward Faught ,Ingrid Scheffer ,Konrad Werhahn ,Helen Cross ,Vicente Villanueva ,Judith Luker ,Erica Puntel ,Iloe Leppik ,Michaela Gelfand ,Wendyr Trueblood Miller ,Shikha Polega ,Melindas Martin ,Global Communications ,Global Medical Affairs ,Twitter ,American Epilepsy Society ,Ucb Inc ,Subgroup Data From International ,Zogenix Inc ,Health Disparities ,European Society Of Cardiology ,Music City Center ,Epilepsy Foundation ,Program See Boxed Warning ,Us Communications ,Group Of Companies ,European Respiratory Society ,Bull World Health Organ ,Annual Meeting ,Black Patients Living ,Davidson Ballroom ,Does Clinical Experience Become Real World ,Expert Perspectives ,Term Treatment ,Rare Syndromes ,Outcomes During Brivaracetam Treatment ,Seizure Freedom Status ,China Dave ,Session Number ,Month Effectiveness ,Prior Antiseizure Medications ,Patients With Epilepsy Aged ,Analysis Vicente Villanueva ,Pediatric Patients ,Subgroup Data From ,Behavioral Effects ,Adjunctive Brivaracetam ,Focal Seizures ,Final Data From ,Open Label Follow Up Trial Jan Peer Elshoff ,Follow Up Trial Kerstin Alexandra Klotz ,Lifetime Antiseizure Medications ,Focal Onset Seizures ,Pooled Data From Two Real World ,Patients Aged Allison Little ,Concomitant Levetiracetam ,Brivaracetam Initiation ,Post Hoc Analysis ,Levetiracetam Discontinuation Status Michael ,Treatment Is Associated With Improvement ,Everyday Executive Function ,Adults With Lennox Gastaut Syndrome ,Dose Effects From ,Safety Analysis ,Ongoing Open Label Extension Study ,Generalized Tonic Clonic Seizures ,Epileptic Encephalopathies ,World Analysis ,Fenfluramine Discontinuation Rates ,Dravet Syndrome ,Patients With Lennox Gastaut Syndrome ,Subgroup Analysis ,Drop Seizure Frequency Reduction ,Open Label Extension ,Event Analysis ,Measure Treatment Effect ,Fenfluramine Therapy ,Pooled Analysis ,Two Phase ,Interim Analysis ,Active Comparator ,Antiseizure Medication Use ,Year Prior ,Initiating Midazolam Nasal Spray ,Diazepam Rectal Gel ,Diazepam Nasal ,Angela Ting ,Self Management Intervention ,New Onset Seizures ,Patient Activation Theory ,Adult Epilepsy Self Management Measurement ,Euronext Brussels ,Safety Information ,Overdose There ,European Summary ,Product Characteristics ,Adverse Reactions ,Antiepileptic Drugs ,Boxed Warning ,Heart Disease ,Pulmonary Arterial Hypertension ,Mitigation Strategy ,Decreased Weight ,Blood Pressure ,Plus Clobazam ,Central Nervous System ,Vimpat Syrup ,Drug Reaction ,Systemic Symptoms ,Cardiorespiratory Adverse ,Nervous System Depression ,Concomitant Use ,World Health ,Who Can Get ,Accessed November ,Ucb ,